Qatar Biomedical Research Institute (QBRI) is a pioneering national research institute within Hamad bin Khalifa University (HBKU) that aims to improve and transform healthcare through innovation in prevention, diagnosis, and treatment of diseases affecting the Qatari population and the region.
We are at the forefront of the development of advanced national facilities, cutting-edge technologies, and enabling platforms as new scientific discoveries are translated into better therapies and strategies, to combat diseases. As a disease-focused institute we concentrate on applying integrative and multidisciplinary approaches to provide novel insights into the molecular basis of the health challenges of breast cancer; type 2 diabetes; neurological disorders such as dementia and autism; and the development of novel biomarkers, diagnostic and therapeutic strategies. Our aim is to facilitate early diagnosis, treatment, and management of these devastating diseases towards improving personalized medicine and healthcare.
In keeping with Qatar National Health priorities and Qatar National Research Strategy, we operate three scientific centers of excellence:
Our flexible structure allows us to respond to the rapidly changing medical, biomedical, and health needs of Qatari society and industry. This enables rapid adjustment to new scientific and technological advances, which in turn empowers us to remain at the forefront of biomedical research.
We are committed to the training and development of the next generation of scientists and highly skilled workers by providing mentoring, advanced scientific and research training opportunities, and career guidance to young scientists.
Our faculty members belong to one of five academic colleges and actively engage their students with the transfer of knowledge they've spent a lifetime acquiring.